Home > Products > Liver Health > Milk Thistle and Dandelion

Milk Thistle and Dandelion

Milk thistle and dandelion are herbs that traditionally being used as liver tonic. The combination of milk thistle and dandelion in one formulation helps to promote liver health.

  • The core constituent of milk thistle is silymarin that exhibits liver-protective properties.
  • Silybin is one of the most active ingredients in silymarin.1
  • Dandelion is a nutritious healing herb with a medicinal reputation for centuries.
  • Silybin acts as an antioxidant to scavenge free radicals and inhibit lipid peroxidation.2
  • Silybin helps in detoxification by blocking the release and reabsorption of foreign substances.3
  • Silybin enhances the protein synthesis which stimulate the regeneration and repair of liver cells.4
  • Dandelion increases the bile release from gall bladder (cholagogue effect).5
  • This enhances the bile production in the liver (choleretic effect) which aids in fat digestion.6
  • Dandelion has diuretic effect which helps to eliminate toxins out of the body.7
  • Those who are having unhealthy or stressful lifestyle
  • Those who wish to maintain their liver health

Adults: One tablet 3 times daily with food or as recommended by your health professional.

Children: One tablet daily with food or as recommended by your health professional.

  • 2 herbs in one formulation to protect liver
  • Suitable for vegetarians
  1. Crocenzi FA and Roma MG. 2006. Silymarin as a new hepato-protective agent in experimental cholestasis: New possibilities for an ancient medication. Current Medicinal Chemistry, 13: 1055–1074.
  2. Flora K, Hahn M, Rosen H, et al. 1998. Milk thistle (Silybum marianum) for the therapy of liver disease. American Journal of Gastroenterology, 93: 139–143.
  3. Loguercio C and Festi D. 2011. Silybin and the liver: From basic research to clinical practice. World Journal of Gastroenterology. 17(18): 2288-2301.
  4. Hackett ES, Twedt DC, and Gustafson DL. 2013. Milk Thistle and Its Derivative Compounds: A Review of Opportunities for Treatment of Liver Disease. Journal of Veterinary Internal Medicine, 27:10-16.
  5. Vogel G. 1977. Natural substances with effects on the liver. In: Wagner H, Wolff P, eds. New Natural Products and Plant Drugs with Pharmacological, Biological or Therapeutic Activity. Heidelberg: Springer-Verlag.
  6. Bohm K. 1959. Choleretic action of some medicinal plants. Arzneimittel-Forschung, 9:376-378.
  7. Chakurski I, Matev M, Koichev A, et al. 1981. Treatment of chronic colitis with an herbal combination of   Taraxacum officinale, Hipericum perforatum, Melissa officinaliss, Calendula officinalis and Foeniculum vulgare. Vutreshni Bolesti, 20:51-4.

 

This is a traditional product advertisement
KKLIU 0814/2016
MAL19986585TCR

Milk Thistle and Dandelion传统上用于滋补肝脏。奶蓟与蒲公英的草药配方,有助于维护肝脏健康

  • 水飞蓟素乃是奶蓟的主要成分,拥有保护肝脏的功能。
  • 其中,水飞蓟宾(silybin)是水飞蓟素里最有活性的成份。1  
  • 蒲公英是一种营养丰富、有愈合效果的药草,已有数百年的医疗历史。
  • 水飞蓟宾作为抗氧化剂,清除自由基和抑制脂质过氧化。2
  • 水飞蓟宾阻止外来物质的释放与吸收,有助于排毒。3
  • 水飞蓟宾促进蛋白质的合成并激发肝细胞的再生与修复。4
  • 蒲公英增加从胆囊释放的胆汁(利胆作用)。5
  • 这可促进肝脏的胆汁分泌(利胆作用),有助于消化脂肪。6
  • 蒲公英具有利尿作用,有助于把毒素排出体外。7
  • 拥有不良或压力大的生活作息者
  • 想要维护肝脏健康者

成人:每天3次,每次随餐1粒锭丸或依您的健康专家建议
小孩(6至12岁):每天随餐1粒锭丸或依您的健康专家建议

  • 二合一的草药配方以保护肝脏
  • 适用于素食者
  1. Crocenzi FA and Roma MG. 2006. Silymarin as a new hepato-protective agent in experimental cholestasis: New possibilities for an ancient medication. Current Medicinal Chemistry, 13: 1055–1074.
  2. Flora K, Hahn M, Rosen H, et al. 1998. Milk thistle (Silybum marianum) for the therapy of liver disease. American Journal of Gastroenterology, 93: 139–143.
  3. Loguercio C and Festi D. 2011. Silybin and the liver: From basic research to clinical practice. World Journal of Gastroenterology. 17(18): 2288-2301.
  4. Hackett ES, Twedt DC, and Gustafson DL. 2013. Milk Thistle and Its Derivative Compounds: A Review of Opportunities for Treatment of Liver Disease. Journal of Veterinary Internal Medicine, 27:10-16.
  5. Vogel G. 1977. Natural substances with effects on the liver. In: Wagner H, Wolff P, eds. New Natural Products and Plant Drugs with Pharmacological, Biological or Therapeutic Activity. Heidelberg: Springer-Verlag.
  6. Bohm K. 1959. Choleretic action of some medicinal plants. Arzneimittel-Forschung, 9:376-378.
  7. Chakurski I, Matev M, Koichev A, et al. 1981. Treatment of chronic colitis with an herbal combination of   Taraxacum officinale, Hipericum perforatum, Melissa officinaliss, Calendula officinalis and Foeniculum vulgare. Vutreshni Bolesti, 20:51-4.

 

此为传统药物广告
KKLIU 0814/2016
MAL19986585TCR

Milk Thistle and Dandelion merupakan herba yang digunakan secara tradisional sebagai tonik hati. Gabungan milk thistle dan dandelion dalam satu formulasi membantu menggalakkan kesihatan hati.

  • Kandungan utama milk thistle adalah silymarin yang mempunyai sifat pelindung hati.
  • Silybin merupakan salah satu kandungan yang paling aktif dalam silymarin1.
  • Dandelion adalah herba berkhasiat dengan reputasi perubatan selama beberapa abad.
  • Silybin berfungsi sebagai antioksida untuk menghapuskan radikal bebas dan menghalang pengoksidaan lemak2.
  • Silybin membantu dalam detoksifikasi dengan menyekat pembebasan dan penyerapan semula bahan-bahan asing3.
  • Silybin meningkatkan sintesis protein yang merangsang pertumbuhan semula dan membaiki sel-sel hati4.
  • Dandelion meningkatkan pembebasan hempedu dari pundi hempedu5.
  • Ini dapat meningkatkan pengeluaran hempedu di dalam hati (kesan koleretik) yang membantu dalam penghadaman lemak6.
  • Dandelion mempunyai kesan diuretik yang membantu untuk menghapuskan toksin daripada badan7.
  • Mempunyai gaya hidup yang tidak sihat atau tertekan
  • Sesiapa yang ingin menjaga kesihatan hati mereka

Dewasa: Satu tablet tiga kali sehari lepas makan ataupun seperti yang dicadangkan oleh professional kesihatan anda.

Kanak-kanak (6-12 tahun): Satu tablet sehari lepas makan ataupun seperti yang dicadangkan oleh professional kesihatan anda.

  • Dua jenis herba dalam satu formulasi untuk perlindungan hati
  • Sesuai untuk vegetarian
  1. Crocenzi FA and Roma MG. 2006. Silymarin as a new hepato-protective agent in experimental cholestasis: New possibilities for an ancient medication. Current Medicinal Chemistry, 13: 1055–1074.
  2. Flora K, Hahn M, Rosen H, et al. 1998. Milk thistle (Silybum marianum) for the therapy of liver disease. American Journal of Gastroenterology, 93: 139–143.
  3. Loguercio C and Festi D. 2011. Silybin and the liver: From basic research to clinical practice. World Journal of Gastroenterology. 17(18): 2288-2301.
  4. Hackett ES, Twedt DC, and Gustafson DL. 2013. Milk Thistle and Its Derivative Compounds: A Review of Opportunities for Treatment of Liver Disease. Journal of Veterinary Internal Medicine, 27:10-16.
  5. Vogel G. 1977. Natural substances with effects on the liver. In: Wagner H, Wolff P, eds. New Natural Products and Plant Drugs with Pharmacological, Biological or Therapeutic Activity. Heidelberg: Springer-Verlag.
  6. Bohm K. 1959. Choleretic action of some medicinal plants. Arzneimittel-Forschung, 9:376-378.
  7. Chakurski I, Matev M, Koichev A, et al. 1981. Treatment of chronic colitis with an herbal combination of   Taraxacum officinale, Hipericum perforatum, Melissa officinaliss, Calendula officinalis and Foeniculum vulgare. Vutreshni Bolesti, 20:51-4.

 

Ini adalah iklan produk tradisional
KKLIU 0814/2016
MAL19986585TCR

BUY NOW
Why Join
BLPC member?

Join us as your health deserve more!

Sign up and receive FREE monthly E-newsletter on latest health/wellbeing article and discount voucher for your purchase of BiO-LiFE product at participating outlets.

Enjoy our periodic redemption program, product launch activity exclusively for BLPC members.

JOIN NOW!
FAQ

Q1: What is non-alcoholic fatty liver disease (NAFLD)?

  • NAFLD is a term used to describe the accumulation of fat within the liver that is not caused byexcessive consumption of alcohol.
  • NAFLD is more likely to happen in people who are overweight or obese and diabetic.
  • In some people with NAFLD, the accumulation of fat can lead to inflammation and scarring in the liver which is known as non-alcoholic steatohepatitis (NASH).
  • Those with NASH may develop fibrosis where persistent inflammation in the liver causes the generation of fibrous scar tissues around the liver cells and blood vessels.
  • At the final stage, the progressive development of scar tissues distorts liver structure and eventually resulting in cirrhosis.
  • The damage caused by cirrhosis is permanent and irreversible. It progresses slowly over years and gradually disturbing your liver function which can lead to liver failure and death.

Q2: Is obesity associated with NAFLD?

  • The basic cause of NAFLD is insulin resistance, a condition where the body is unable to utilize insulin efficiently.
  • This condition is mainly due to obesity, especially central obesity (excessive abdominal fats accumulate around stomach and abdomen).
  • Fatty liver can disappear if the person is successfully losing weight.
  • However, it may progress to next stage from time to time when there is accumulation of fat in the liver.
FAQ

Q1: 什么是非酒精性脂肪(NAFLD)?

  • 非酒精性脂肪肝是指非过度饮酒而造成的肝内脂肪囤积。
  • 非酒精性脂肪肝比较普遍于超重或肥胖者及糖尿病患者。
  • 在一些非酒精性脂肪肝患者当中,堆积的脂肪会导致肝脏发炎和伤疤,这被称为非酒精性脂肪肝炎(NASH)。
  • 那些患有非酒精性脂肪肝炎者可能会恶化为肝纤维化,由于肝脏持续发炎而导致周围肝细胞和血管纤维化。
  • 在最后阶段,纤维化的肝细胞将扭曲肝脏结构并引起肝硬化。
  • 肝硬化带来的伤害是永久而不能被逆转的。它将会慢慢地形成,逐渐破坏您的肝脏功能并导致肝衰竭而死亡。

Q2: 痴肥是否与非酒精性脂肪肝有关联?

  • 非酒精性脂肪肝发生的根本因素是胰岛素抵抗的现象,这表示身体无法有效地善用胰岛素。
  • 这种情况主要是因肥胖而造成,尤其是中心性肥胖(多余的脂肪堆积在腹部)。
  • 假如减肥成功,那么脂肪肝也会随着消失。
  • 然而,它也随时可能进入下个阶段倘若脂肪囤积在肝脏。
FAQ

Q1: Apakah perlemakan hati non-alkoholik?

  • Perlemakan hati non-alkoholik merupakan istilah yang digunakan untuk menerangkan pengumpulan lemak dalam hati yang tidak disebabkan oleh penggunaan alkohol yang berlebihan.
  • Perlemakan hati non-alkoholik biasanya berlaku pada mereka yang mempunyai berat badan berlebihan atau obes dan diabetes.
  • Dalam sesetengah orang yang mempunyai perlemakan hati non-alkoholik, pengumpulan lemak boleh menyebabkan keradangan dan parut di dalam hati yang dikenali sebagai steatohepatitis non-alkoholik.
  • Mereka yang menghidapi steatohepatitis non-alkoholik akan mengalami fibrosis di mana keradangan berterusan dalam hati boleh menyebabkan penjanaan tisu parut sekitar sel hati dan saluran darah.
  • Pada peringkat yang terakhir, pembentukan tisu parut yang progresif akan memesongkan struktur hati dan akhirnya mengakibatkan sirosis.
  • Kerosakan yang disebabkan oleh sirosis adalah kekal dan tidak boleh diubah. Ia terbentuk perlahan-lahan selama bertahun-tahun dan mengganggu fungsi hati anda secara beransur-ansur dan boleh menyebabkan kegagalan fungsi hati dan kematian.

Q2: Adakah obesiti dikaitkan dengan perlemakan hati non-alkoholik?

  • Punca asas perlemakan hati non-alkoholik merupakan rintangan insulin, keadaan yang di mana badan tidak dapat menggunakan insulin dengan berkesan.
  • Keadaan ini disebabkan oleh obesiti, terutamanya obesiti sentral (lemak perut yang berlebihan berkumpul di sekitar perut dan abdomen).
  • Perlemakan hati boleh hilang sekiranya seseorang itu berjaya mengurangkan berat badan.
  • Walau bagaimanapun, ia boleh berkembang ke peringkat seterusnya dari semasa ke semasa apabila terdapat pengumpulan lemak di dalam hati.
BACK
HealthCare As Nature Intended